Literature DB >> 2469601

Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A.

K von der Helm1, L Gürtler, J Eberle, F Deinhardt.   

Abstract

After incubation of H9 cells infected with human immunodeficiency virus (HIV) with pepstatin A at 10(-4) M for 2, 4, or 11 days, the culture medium contained significantly less HIV core antigen (p24) than controls without pepstatin A and no or only borderline activity of reverse transcriptase was detected. In addition, after pepstatin A treatment no infectious HIV at 2 or 4 days and only minimal amounts at 11 days were detectable in the culture medium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2469601     DOI: 10.1016/0014-5793(89)81368-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Human immunodeficiency virus type 1 proteinase resistance to symmetric cyclic urea inhibitor analogs.

Authors:  U Nillroth; L Vrang; P O Markgren; J Hultén; A Hallberg; U H Danielson
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

2.  Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.

Authors:  R L Shoeman; C Sachse; B Höner; E Mothes; M Kaufmann; P Traub
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

3.  An assay to monitor HIV-1 protease activity for the identification of novel inhibitors in T-cells.

Authors:  Brett J Hilton; Roland Wolkowicz
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

4.  Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor.

Authors:  H Schätzl; H R Gelderblom; H Nitschko; K von der Helm
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.